改良小口径人工血管的血液相容性研究  

The Study of the Modified Small-caliber Artificial Blood Vessel

作　　者：李辉[1] 陈群清[1] 李少彬[1] 闫玉生[1] 

机构地区：[1]南方医科大学珠江医院,广东广州510282

出　　处：《中国医学创新》2013年第15期10-12,共3页Medical Innovation of China

基　　金：2010年新疆哈密地区科技计划项目(编号:第26号);广东省医学科学技术研究基金(编号:WSTJJ20071104410303197905132512)

摘　　要：目的:研究改良小口径人工血管的血液相容性。方法:将丝素蛋白膜涂覆于聚四氟乙烯小口径人工血管内侧壁,采用等离子体技术对涂覆后的小口径人工血管磺酸化,制成改良小口径人工血管;改良小口径人工血管的溶血相关安全性以体外溶血实验检测,同时行动态凝血、复钙实验评价复合血管血液相容性。结果:溶血试验提示复合血管的溶血率为4.5%,符合材料溶血要求;动态凝血中根据各时间点吸光度平均值可见复合血管组吸光度整体位于普通血管之上,且下降趋势较缓,经历时间较长,与普通血管相比,其抗凝血性能较好;复钙实验中复合血管组平均时间为(450.00±32.18)s,小于对照组平均时间(610.06±37.65)s,两样本t检验提示P=0.000,提示两者差异有统计学意义。结论:改良小口径人工血管具有良好的血液相容性。Objective： To research the hemocompatibility of the modified small-caliber artificial blood vessel （ the combined blood vessel ） . Method： To produce a combined blood vessel with a small-caliber expanded polytetrafluoroethylene vessel coated by silk fibroin film, which sulfonated by low temperature plasma treatment, to evaluated the hemocompatibility and safety of the combined blood vessel including dynamic cruor time test, recalcification time, and the hemolysis test.Result： Hemolytic test indicated that the vascular hemolysis was 4.5%, in line with the requirements of materials hemolytic.The average value of absorbance-clotting time of the combined blood vessel was higher than that of the control blood vessel, and declined more slowly.The recalcification time of the combined blood vessel was significantly longer than that of control blood vessel （ 610.06 ± 37.65 vs 450.00 ± 32.18 seconds, P〈O.01 ） .Conclusion： Form this experiment, we demonstrate the combined blood vessel has a good hemocompatibility.

关 键 词：人工血管 血液相容性 凝血实验 复钙实验 

分 类 号：R318.08[医药卫生—生物医学工程]